Clinical Studies

Development of a safe and beneficial immunotherapy option for canine urothelial carcinoma patients will advance veterinarians' ability to treat this disease and will provide an important model to inform future canine and human clinical trials in this area.

This pilot study seeks to evaluate whether this benefit is seen in a larger cohort of dogs with suspected hip OA through the injection of this product in the affected hip joint.